2013: India Battles For Right To Use Compulsory Licences To Make Medicines AffordablePublished on 22 January 2013 @ 5:41 pm
By Patralekha Chatterjee for Intellectual Property Watch
India has started the New Year on a volatile note. With general elections looming in 2014, there is turbulence and not just in the political world. In India’s pharmaceutical industry, there is sparring over the prickly issue of ‘compulsory licenses’, a mechanism by which a government allows a domestic company to manufacture and sell a generic version of a patented drug without the consent of the patent-holder, who receives compensation.